Section Editors

Elias Jabbour - University of Texas MD Anderson Cancer Center

Elias Jabbour

University of Texas MD Anderson Cancer Center

Dr. Elias Jabbour graduated from the Saint Joseph’s School of Medicine in 1998 and joined, thereafter, the Hotel Dieu de France University Hospital as a resident. In 2001, he pursued in fellowship in Hematology-Oncology at the Gustave Roussy Institute. In 2003, he joined the University of Texas M. D. Anderson Cancer as a fellow in the Department of Hematology/Leukemia and Stem cell transplantation. Thereafter, in 2007, he joined the faculty in the Leukemia department as Assistant Professor. Dr. Jabbour is actively involved in research in both acute and chronic forms of leukemia. He was actively involved in clinical trials that lead to the approval of several drugs in chronic myeloid leukemia (CML) and myelodysplastic syndromes. His research on resistance to imatinib and mutations of the protein kinase domain were presented in several international; meetings and published in peer-reviewed journals. He is also developing tailored therapies to CML.

Michele Baccarani - Head, Institute of Hematology and Medical Oncology, “L and A Sercignoli”, S Orsala University Hospital, Professor of Hematology, University of Bologna

Michele Baccarani

Head, Institute of Hematology and Medical Oncology, “L and A Sercignoli”, S Orsala University Hospital, Professor of Hematology, University of Bologna

Prof. Baccarani is Chairman of the Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA) chronic myeloid leukaemia (CML) Working Party (formerly the Italian Cooperative Study Group on CML) and of the CML working group of the European LeukemiaNet.

Prof. Baccarani is the first or contributing author on over 600 publications in the field of haematology.

Previously, he was Professor of Haematology at the University of Bologna and Head of the Department of Haematology and Oncology ‘L and A Seràgnoli’ at the S Orsola-Malpighi University Hospital, Bologna until November 2012. He headed the Division of Haematology and Bone Marrow Transplantation of Udine University Hospital during his post as a Professor of Haematology at Udine University. He has also held faculty positions as a Professor of Haematology at Trieste University and of Cancer Chemotherapy at Chieti University.

He is Past President of both the Italian Society of Haematology and the Italian Society of Experimental Haematology

Latest Articles

European Oncology & Haematology. 2018;14(1):18–19 DOI: https://doi.org/10.17925/EOH.2018.14.1.18

Latest Videos

Video List based on Category on Node Page

Latest Videos

touchONCOLOGY talks to Arnon P Kater from the Academisch Medisch Centrum Universiteit van Amsterdam about the MURANO study and the impact of TP53-mutated clone size on outcome of relapsed/refractory (R/R) CLL patients treated with venetoclax plus rituximab. 1. Why do chronic lymphocytic...
Annalisa Chiapella from Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino in Italy talks to touchONCOLOGY about patients with diffuse large B-cell lymphoma (DLBCL) with a TP53 mutation, and the aims and findings of the FIL-DLCL04 study to help tackle...
We catch up with editorial board member Willem Fibbe from Leiden University Medical Centre to discuss mesenchymal stromal cells and their therapeutic potential in the clinic. 1. What properties of mesenchymal stromal cells (MSCs) have led to the investigation of their therapeutic...

Haematological Malignancies INSIGHTS

The touchONCOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of oncology:

Insight
2017 – a Landmark Year for Food and Drug Administration Approvals for Haematological Malignancies Katrina Mountfort, Senior Medical Writer, Touch Medical Media, Reading, UK
Tim Sheldrick, Group Director and Advisory Editor, Touch Medical Media, Reading, UK